| Circadian Character of Food Compulsions and Impulses Control Disorders in Parkinsonian Patients With and Without Resting Leg Syndrome (NCT03818243) | University Hospital, Clermont-Ferrand | 2019-01-21 |
| Restless Legs Syndrome in Hemodialysis Patients (NCT03337529) | Makassed General Hospital | 2017-09-15 |
| Restless Leg Syndrome and Severe Preeclampsia (NCT01538147) | Saint Thomas Hospital, Panama | 2017-08-01 |
| Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome (NCT02117076) | Theresa Zesiewicz, MD | 2014-04-01 |
| Sleep Quality in Pregnancy and Its Impact on Pregnancy Outcomes (NCT02016638) | All India Institute of Medical Sciences | 2013-03-01 |
| Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome. (NCT01931878) | Yale University | 2012-09-01 |
| Fire Fighter Fatigue Management Program: Operation Fight Fatigue (NCT01672502) | Brigham and Women's Hospital | 2012-09-01 |
| Probiotics in the Treatment of Iron Deficiency in Children With Restless Leg Syndrome (NCT01617044) | Children's Hospitals and Clinics of Minnesota | 2012-05-01 |
| Restless Legs Syndrome With Iron Deficiency or Anaemia in the 3rd Trimester of Pregnancy (NCT01245777) | University of Zurich | 2009-10-01 |
| New Data Analysis Methods for Actigraphy in Sleep Medicine (NCT00949858) | Washington University School of Medicine | 2009-07-01 |
| RESTIFFIC™ Foot Wrap Reduces Moderate to Severe Restless Leg Syndrome (NCT02386423) | Lake Erie Research Institute | 2009-04-01 |
| Fire Fighter Fatigue Management Program: Operation Healthy Sleep (NCT01988129) | Brigham and Women's Hospital | 2009-03-01 |
| Neuraxial Anesthesia and Restless Leg Syndromes in Cesarean (NCT00872248) | Nanjing Medical University | 2009-02-01 |
| Prevalence of OSAS in Chinese Elderly and Its CPAP Compliance (NCT02085720) | Chinese University of Hong Kong | 2007-09-01 |
| A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Und Fasted Conditions (NCT00673088) | Roxane Laboratories | 2004-02-01 |
| A Single-Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Ropinirole 0.25 mg Tablets Under Fed Conditions (NCT00674310) | Roxane Laboratories | 2004-02-01 |